Document is current
Any future updates will be listed below
-
Authors
Grohmann, Christoph http://orcid.org/0000-0003-2389-5807
Walker, Francesca
Devlin, Mark
Luo, Meng-Xiao
Chüeh, Anderly C.
Doherty, Judy
Vaillant, François http://orcid.org/0000-0003-3229-3760
Ho, Gwo-Yaw http://orcid.org/0000-0003-1195-2296
Wakefield, Matthew J. http://orcid.org/0000-0001-6624-4698
Weeden, Clare E. http://orcid.org/0000-0002-1561-1416
Kamili, Alvin
Murray, Jayne
Po’uha, Sela T.
Weinstock, Janet
Kane, Serena R.
Faux, Maree C.
Broekhuizen, Esmee
Zheng, Ye
Shield-Artin, Kristy
Kershaw, Nadia J.
Tan, Chin Wee http://orcid.org/0000-0001-9695-7218
Witchard, Helen M.
Ebert, Gregor http://orcid.org/0000-0002-5318-3037
Charman, Susan A.
Street, Ian
Kavallaris, Maria
Haber, Michelle http://orcid.org/0000-0003-2036-8817
Fletcher, Jamie I. http://orcid.org/0000-0003-2949-9469
Asselin-Labat, Marie-Liesse http://orcid.org/0000-0001-7082-6076
Scott, Clare L.
Visvader, Jane E.
Lindeman, Geoffrey J. http://orcid.org/0000-0001-9386-2416
Watson, Keith G.
Burgess, Antony W.
Lessene, Guillaume http://orcid.org/0000-0002-1193-8147
-
Funding
Funding for this research was provided by:
Cooperative Research Centres, Australian Government Department of Industry
Department of Health | National Health and Medical Research Council (487922, 1113133, APP1057805, 1057805, 1057805, APP1119152, 1037230, 1078730, 1057805)
Cancer Council Victoria
Victorian Cancer Agency (CRF1020)
- License Information
-
More Information
Article History
Received: 2 April 2020
Revised: 1 October 2020
Accepted: 2 October 2020
First Online: 12 March 2021
Conflict of interest
: A.W.B., F.W., K.G.W., H.M.W. and G.L. have intellectual property rights in the anti-cancer compound WEHI-7326 described in this manuscript. The remaining authors declare that they have no conflict of interest.
